Clariane SE (EPA: CLARI)
France
· Delayed Price · Currency is EUR
1.760
-0.070 (-3.83%)
Dec 3, 2024, 3:55 PM CET
Clariane SE Revenue
Clariane SE had revenue of 2.63B EUR in the half year ending June 30, 2024, with 21.85% growth. This brings the company's revenue in the last twelve months to 5.17B, up 9.18% year-over-year. In the year 2023, Clariane SE had annual revenue of 5.00B with 12.56% growth.
Revenue (ttm)
5.17B
Revenue Growth
+9.18%
P/S Ratio
0.00
Revenue / Employee
86.17K
Employees
60,000
Market Cap
651.36M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.00B | 557.29M | 12.56% |
Dec 31, 2022 | 4.44B | 300.99M | 7.27% |
Dec 31, 2021 | 4.14B | 364.40M | 9.66% |
Dec 31, 2020 | 3.77B | 160.41M | 4.44% |
Dec 31, 2019 | 3.61B | 276.02M | 8.27% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 48.45B |
EssilorLuxottica Société anonyme | 25.83B |
Sartorius Stedim Biotech S.A. | 2.74B |
bioMérieux S.A. | 3.81B |
Ipsen S.A. | 3.44B |
Eurofins Scientific SE | 6.72B |
Virbac SA | 1.34B |
Ramsay Générale de Santé SA | 5.01B |